Categories
  Encyclosphere.org ENCYCLOREADER
  supported by EncyclosphereKSF

Dapolsertib

Topic: Chemistry

 From HandWiki - Reading time: 1 min

Dapolsertib is an investigational new drug that is being evaluated for the treatment of cancer. It is dual inhibitor of PIM family of serine/threonine protein kinases and mutant forms of FMS-related tyrosine kinase 3 (FLT3) that is being developed by Ryvu Therapeutics SA.[1]

References

  1. ↑ "FLT3 inhibitors in acute myeloid leukemia". Journal of Hematology & Oncology 11 (1). December 2018. doi:10.1186/s13045-018-0675-4. PMID 30514344. 




Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Dapolsertib&oldid=4038306"
Licensed under CC BY-SA 3.0 | Source: https://handwiki.org/wiki/Chemistry:Dapolsertib
1 views |
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF